<DOC>
	<DOC>NCT02026310</DOC>
	<brief_summary>All the guidelines suggest that metformin as the basis of type 2 diabetes medication, and evidence is sufficient.At the same time the basal insulin injection once a day are more and more widely used in diabetes patients in China. This study aims to evaluate the efficacy and safety of adding glimepiride to type 2 diabetes patients with inadequate glycemic control with combined therapy of metformin and basal insulin.</brief_summary>
	<brief_title>Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Understand the whole test process, voluntary and signed informed consent form Men and women aged 35 to 70 years old 20≤BMI&lt;35 Kg/m2 Diagnosed with type 2 diabetes Undergoing metformin(Dose not less than 1000 mg/day)in combination with basal insulin injection once a day HbA1c7.0－11% Patients should be able to self blood glucose monitoring sulfonylureas,glinides,TZDs use within 3 months before the study Pregnant or lactating women A history of ketoacidosis Allergy to sulfonylureas or sulfa drug patients Apparent dysfunction of liver and kidney patients(ALT&gt;2 times upper normal limit,serum creatinine&gt;1.2 times upper normal limit) Poor blood pressure control(systolic pressure&gt;180mmHg or diastolic blood pressure&gt;110mmHg) heart disease,cardiac insufficiency,unstable angina pectoris,ECG indicates left ventricle hypertrophy,severe anemia(Hb&lt;9.0g/d1) Severe diabetic nerve complications(ulcer of lower limb,neurogenic bladder) BMI&lt;20 orBMI≥35kg/m2 Alcohol or drug abuse ,or can't collaborate due to mental disorder Digestion and absorption function obstacle or Other endocrine disorders Other chronic diseases required longterm glucocorticoid treatment</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>glimepiride</keyword>
	<keyword>metformin</keyword>
	<keyword>basal insulin</keyword>
	<keyword>Hemoglobin A, Glycosylated</keyword>
	<keyword>glucose fluctuation</keyword>
	<keyword>hypoglycemia</keyword>
</DOC>